PLG and thrombotic thrombocytopenic purpura: The resultant indirect inhibition of fibrin breakdown could not only lessen TTP-associated bleeding in this model but also redirect the actions of plasminogen and tPA away from fibrin clots, allowing more plasminogen and tPA to be available for platelet-VWF binding and degradation than would be expected in humans.